Nobivac® Canine 1-DAPPv
Manufacturer: Intervet/Merck Animal Health
Canine Distemper-adenovirus Type 2-parainfluenza-parvovirus Vaccine
Modified Live Virus
Approved for the vaccination of healthy dogs as an aid in the prevention of disease caused by canine distemper virus, adenovirus types 1 and 2, parainfluenza, and parvovirus
Recommended for use in healthy dogs 6 weeks of age or older
Data indicate the development of corneal opacity is not associated with the use of this product.
Features and benefits:
- High antigenic mass (titer), low passage parvovirus vaccine
- Canine vaccine containing CPV-2b, the most prevalent field strain of parvovirus
- Protects against 2 types of adenovirus that cause hepatitis and respiratory disease in dogs
- Provides disease coverage for commonly spread canine viruses, distemper, adenovirus types 1 and 2, and parainfluenza in 1 formula
Nobivac Canine 1-DAPPv Dosage And Administration
Transfer contents of the sterile diluent vial to the Nobivac®: Canine 1-DAPPv vial aseptically. Mix gently until dissolved. Use entire contents immediately after rehydration.
Inject one dose (1 mL) subcutaneously or intramuscularly. The initial dose may be given at 6 weeks of age or older. Repeat at 2 to 4 week intervals until the dog is 12 weeks of age. A minimum of two doses is required for primary immunization. Annual revaccination with one dose is recommended. Following the advice of the American Veterinary Medical Association on Vaccination Principles, an appropriate revaccination program for individual animals should be made based upon veterinarian-client-patient relationships.
This item is NON-RETURNABLE and NON-REFUNDABLE.